Institutions / Tekla Capital Management LLC
Tekla Capital Management LLC
CIK 1300336 · Institution · as of Dec 31, 2021
Portfolio value
$3.11B
Positions
171
As of
Dec 31, 2021
Portfolio trend
Portfolio value
$3.11B+0.1%Positions
171-0.6%Top holdings
Dec 31, 2021View all 171 →
| Company | Value | % of portfolio |
|---|---|---|
| Unitedhealth Group Inc | $160.86M | 5.2% |
| Moderna, Inc. | $138.83M | 4.5% |
| Amgen Inc | $129.34M | 4.2% |
| Gilead Sciences, Inc. | $122.46M | 3.9% |
| Thermo Fisher Scientific Inc. | $101.64M | 3.3% |
| Horizon Therapeutics plc | $96.72M | 3.1% |
| Regeneron Pharmaceuticals, Inc. | $90.34M | 2.9% |
| Johnson & Johnson | $88.38M | 2.8% |
| Illumina, Inc. | $86.06M | 2.8% |
| Abbott Laboratories | $82.09M | 2.6% |
| Pfizer Inc | $69.20M | 2.2% |
| AbbVie Inc. | $69.03M | 2.2% |
| Danaher Corp /De | $66.58M | 2.1% |
| ELI LILLY & Co | $63.65M | 2.0% |
| Seagen Inc. | $61.77M | 2.0% |
| Merck & Co., Inc. | $60.40M | 1.9% |
| Vertex Pharmaceuticals Inc / Ma | $59.96M | 1.9% |
| Idexx Laboratories Inc /De | $52.45M | 1.7% |
| Medtronic plc | $52.33M | 1.7% |
| Stryker Corp | $49.09M | 1.6% |
| McKesson Corp | $46.86M | 1.5% |
| Bristol Myers Squibb Co | $46.58M | 1.5% |
| AstraZeneca PLC | $45.87M | 1.5% |
| Syneos Health, Inc. | $41.39M | 1.3% |
| Guardant Health, Inc. | $35.16M | 1.1% |
Activity
Dec 31, 2021
InsidersInstitutions
This fund's quarter-over-quarter position changes — what it's buying and selling.No quarter-over-quarter changes yet. Position changes appear once we have two consecutive quarterly reports for this manager. We currently hold 5 quarters of holdings.